2008
DOI: 10.1016/j.sbi.2007.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Structural insights into the exon junction complex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
47
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 95 publications
(48 citation statements)
references
References 36 publications
1
47
0
Order By: Relevance
“…This feedback regulatory response was specific, as the transcript encoding the uniquely weak NMD factor, UPF3A (Kunz et al, 2006; Chan et al, 2009), did not significantly increase in level in response to NMD perturbation, suggesting that it is not feedback regulated (Figure 1A). Also not significantly feedback regulated were the transcripts encoding the core exon-junction complex (EJC) factors (i.e.,Y14, MAGOH, CASC3, and eIF4A3), which all promote mammalian NMD but are not essential for NMD (Figure 1A) (Le Hir and Andersen, 2008; Chan et al, 2009; Rebbapragada and Lykke-Andersen, 2009). As an independent test of feedback regulation by NMD, we treated HeLa cells with the protein synthesis blocker cycloheximide (CHX), a potent inhibitor of the NMD pathway (Carter et al, 1996; Amrani et al, 2004).…”
Section: Resultsmentioning
confidence: 99%
“…This feedback regulatory response was specific, as the transcript encoding the uniquely weak NMD factor, UPF3A (Kunz et al, 2006; Chan et al, 2009), did not significantly increase in level in response to NMD perturbation, suggesting that it is not feedback regulated (Figure 1A). Also not significantly feedback regulated were the transcripts encoding the core exon-junction complex (EJC) factors (i.e.,Y14, MAGOH, CASC3, and eIF4A3), which all promote mammalian NMD but are not essential for NMD (Figure 1A) (Le Hir and Andersen, 2008; Chan et al, 2009; Rebbapragada and Lykke-Andersen, 2009). As an independent test of feedback regulation by NMD, we treated HeLa cells with the protein synthesis blocker cycloheximide (CHX), a potent inhibitor of the NMD pathway (Carter et al, 1996; Amrani et al, 2004).…”
Section: Resultsmentioning
confidence: 99%
“…MAGOH, eIF4A3, Y14, and MLN51 form the core of the EJC that binds to sequences 20 to 24 nucleotides upstream of exon-exon boundaries (43,44). The EJC is recruited to transcripts by the intron-binding protein IBP160 (45) and deposited on the RNA via eIF4A3 prior to exon ligation during splicing (46,47).…”
Section: Resultsmentioning
confidence: 99%
“…The EJC has been implicated in transcription, nuclear mRNA export, nonsense-mediated decay (NMD), and enhanced translation (48)(49)(50)(51). It also acts as a general scaffold for a variety of factors implicated in cotranscriptional mRNA processing, especially 3= end formation (e.g., UPF2, UPF3, and RNPS1) (44). SRSFs are characterized by a common domain organization: one or two N-terminal RNA recognition motifs (RRMs) and a C-terminal Arg-Ser-rich domain (RS domain).…”
Section: Resultsmentioning
confidence: 99%
“…Four proteins form the EJC core: the constitutive heterodimer Magoh/Y14, the DEAD-box RNA helicase eIF4A3 (eukaryotic initiation factor 4AIII), and MLN51 (metastatic lymph node 51), also known as CASC3 and Barentsz (BTZ; Ballut et al , 2005; Tange et al , 2005). EJC cores accompany mRNAs to the cytoplasm, where the translation machinery removes them from open reading frames (Le Hir et al , 2001b; Dostie and Dreyfuss, 2002; Lejeune et al , 2002; Gehring et al , 2009b); they constitute binding platforms for peripheral factors that dynamically associate and dissociate during mRNA travel (Le Hir and Andersen, 2008; Buchwald et al , 2010; Bono and Gehring, 2011). Several functions are attributed to this complex, in both the nucleus and the cytoplasm.…”
Section: Introductionmentioning
confidence: 99%